The association between cancer and amyotrophic lateral sclerosis

The molecular pathology of cutaneous melanoma

(2017) Thomas Bogenrieder et al.   Cancer Biomarkers

Expression of hepatocyte growth factor in the skin of amyotrophic lateral sclerosis

(2011) M. Nomura et al.   ACTA NEUROLOGICA SCANDINAVICA

Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer

(2011) Cecilia L. Speyer et al.   BREAST CANCER RESEARCH AND TREATMENT

Glutamatergic Pathway Targeting in Melanoma: Single-Agent and Combinatorial Therapies

(2011) H. J. Lee et al.   CLINICAL CANCER RESEARCH

Emerging drugs for amyotrophic lateral sclerosis

(2011) Ali Aamer Habib et al.   EXPERT OPINION ON EMERGING DRUGS

Increased progranulin in the skin of amyotrophic lateral sclerosis: An immunohistochemical study

(2011) Kanako Yasui et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Amyotrophic lateral sclerosis

(2011) Matthew C Kiernan et al.   LANCET

No paradox, no progress: inverse cancer comorbidity in people with other complex diseases

(2011) Rafael Tabarés-Seisdedos et al.   LANCET ONCOLOGY

Evaluation of a multifaceted intervention to limit excessive antipsychotic co-prescribing in schizophrenia out-patients

(2010) L. Baandrup et al.   ACTA PSYCHIATRICA SCANDINAVICA

Parkinson’s disease and cancer risk: a systematic review and meta-analysis

(2010) Archna Bajaj et al.   CANCER CAUSES & CONTROL

Patients who survive 5 years or more with ALS in Olmsted County, 1925-2004

(2010) F. J. Mateen et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

An immunohistochemical study of ubiquitin in the skin of sporadic amyotrophic lateral sclerosis

(2010) Takeshi Watanabe et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Factors Affecting Survival of Patients with Neurodegenerative Disease

(2010) Kyle Steenland et al.   NEUROEPIDEMIOLOGY

No Role for Melanoma Treatment in the Association between Melanoma and Amyotrophic Lateral Sclerosis or Parkinson’s Disease

(2010) Peter D. Baade et al.   NEUROEPIDEMIOLOGY

Can Mortality Data Be Used to Estimate Amyotrophic Lateral Sclerosis Incidence?

(2010) Benoît Marin et al.   NEUROEPIDEMIOLOGY

Cancer and Neurodegeneration: Between the Devil and the Deep Blue Sea

(2010) Hélène Plun-Favreau et al.   PLoS Genetics

Prognostic factors in ALS: A critical review

(2009) Adriano Chiò et al.   Amyotrophic Lateral Sclerosis

A Phase 0 Trial of Riluzole in Patients with Resectable Stage III and IV Melanoma

(2009) D. Yip et al.   CLINICAL CANCER RESEARCH

Expression of glutamate receptor subunits in human cancers

(2009) Andrzej Stepulak et al.   HISTOCHEMISTRY AND CELL BIOLOGY

Cancer linked to Alzheimer disease but not vascular dementia

(2009) C. M. Roe et al.   NEUROLOGY

Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis

(2008) Stacey A. Sakowski et al.   Amyotrophic Lateral Sclerosis

Circulating insulin-like growth factor peptides and prostate cancer risk: A systematic review and meta-analysis

(2008) Mari-Anne Rowlands et al.   INTERNATIONAL JOURNAL OF CANCER

Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study

(2008) Jocelyn S. Kasper et al.   INTERNATIONAL JOURNAL OF CANCER

Subcutaneous IGF-1 is not beneficial in 2-year ALS trial

(2008) E. J. Sorenson et al.   NEUROLOGY

Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues

(2007) G Logroscino et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY